These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7852226)

  • 1. Effect of gugulipid on bioavailability of diltiazem and propranolol.
    Dalvi SS; Nayak VK; Pohujani SM; Desai NK; Kshirsagar NA; Gupta KC
    J Assoc Physicians India; 1994 Jun; 42(6):454-5. PubMed ID: 7852226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice.
    Saxena G; Singh SP; Pal R; Singh S; Pratap R; Nath C
    Pharmacol Biochem Behav; 2007 Apr; 86(4):797-805. PubMed ID: 17477963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials with gugulipid. A new hypolipidaemic agent.
    Nityanand S; Srivastava JS; Asthana OP
    J Assoc Physicians India; 1989 May; 37(5):323-8. PubMed ID: 2693440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiperoxide effects of S-allyl cysteine sulphoxide isolated from Allium sativum Linn and gugulipid in cholesterol diet fed rats.
    Sheela CG; Augusti KT
    Indian J Exp Biol; 1995 May; 33(5):337-41. PubMed ID: 7558192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GUGULIPID: a natural cholesterol-lowering agent.
    Urizar NL; Moore DD
    Annu Rev Nutr; 2003; 23():303-13. PubMed ID: 12626688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration.
    Ulbricht C; Basch E; Szapary P; Hammerness P; Axentsev S; Boon H; Kroll D; Garraway L; Vora M; Woods J;
    Complement Ther Med; 2005 Dec; 13(4):279-90. PubMed ID: 16338199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of propranolol's bioavailability by Eurycoma longifolia water-based extract.
    Salman SA; Amrah S; Wahab MS; Ismail Z; Ismail R; Yuen KH; Gan SH
    J Clin Pharm Ther; 2010 Dec; 35(6):691-6. PubMed ID: 21054461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gugulipid: pro-lipaemic effect.
    Gupta RD
    J Assoc Physicians India; 1990 Aug; 38(8):598. PubMed ID: 2246214
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trial of gugulipid--a new hypolipidemic agent of plant origin in primary hyperlipidemia.
    Agarwal RC; Singh SP; Saran RK; Das SK; Sinha N; Asthana OP; Gupta PP; Nityanand S; Dhawan BN; Agarwal SS
    Indian J Med Res; 1986 Dec; 84():626-34. PubMed ID: 3552974
    [No Abstract]   [Full Text] [Related]  

  • 10. A new hypolipidaemic agent (gugulipid).
    Das Gupta R
    J Assoc Physicians India; 1990 Feb; 38(2):186. PubMed ID: 2248657
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioequivalence and relative bioavailability of a new diltiazem sustained release formulation.
    Scheiwe MW; Lankhaar G; Kleinbloesem CH
    Arzneimittelforschung; 1996 Oct; 46(10):960-3. PubMed ID: 8931888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodulocystic acne: oral gugulipid versus tetracycline.
    Thappa DM; Dogra J
    J Dermatol; 1994 Oct; 21(10):729-31. PubMed ID: 7798429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of propranolol on the disposition and negative dromotropic activity of diltiazem in the dog during multiple dosing.
    Maskasame C; Lankford SM; Bai SA
    Drug Metab Dispos; 1993; 21(1):156-61. PubMed ID: 8095211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid lowering effect of S-methyl cysteine sulfoxide from Allium cepa Linn in high cholesterol diet fed rats.
    Kumari K; Augusti KT
    J Ethnopharmacol; 2007 Feb; 109(3):367-71. PubMed ID: 16987625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers.
    Christensen H; Asberg A; Holmboe AB; Berg KJ
    Eur J Clin Pharmacol; 2002 Nov; 58(8):515-20. PubMed ID: 12451428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of diltiazem and propranolol when administered alone and in combination.
    Dimmitt DC; Yu DK; Elvin AT; Giesing DH; Lanman RC
    Biopharm Drug Dispos; 1991 Oct; 12(7):515-23. PubMed ID: 1932613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits.
    Choi JS; Li X
    Int J Pharm; 2005 Jun; 297(1-2):1-8. PubMed ID: 15907592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interactions between topiramate and diltiazem, hydrochlorothiazide, or propranolol.
    Manitpisitkul P; Curtin CR; Shalayda K; Wang SS; Ford L; Heald D
    Clin Pharmacol Drug Dev; 2014 Sep; 3(5):378-87. PubMed ID: 27129011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Commiphora mukul (gum guggulu) in patients of hyperlipidemia with special reference to HDL-cholesterol.
    Verma SK; Bordia A
    Indian J Med Res; 1988 Apr; 87():356-60. PubMed ID: 3169888
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats.
    Li C; Choi JS
    Pharmazie; 2008 Nov; 63(11):815-8. PubMed ID: 19069242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.